BHC
AGN

Bowen Hanes & Co’s Allergan plc AGN Stock Holding History

Bowen Hanes & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-80,420
Closed -$15.3M – 184
2018
Q3 		$15.3M Buy
+80,420
New +$14.8M 0.67% 64
2017
Q4 		– Sell
-100,360
Closed -$20.6M – 149
2017
Q3 		$20.6M Buy
100,360
+16,640
+20% +$3.87M 0.97% 55
2017
Q2 		$20.4M Buy
+83,720
New +$19.7M 1% 54

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Bowen Hanes & Co's AGN Position: Q4 2018 in Review

Bowen Hanes & Co sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 80,420 shares — an estimated $15.3M sold.

Bowen Hanes & Co first reported a position in AGN in Q2 2017 and held it in 3 quarters. The position peaked at $20.6M in Q3 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Bowen Hanes & Co reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Bowen Hanes & Co sold 80,420 Allergan plc shares in Q4 2018, an estimated $15.3M.
  • Bowen Hanes & Co first reported a position in Allergan plc in Q2 2017 and held it in 3 quarters.
  • Bowen Hanes & Co's Allergan plc position peaked at $20.6M in Q3 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Bowen Hanes & Co's 13F filing for Q4 2018, filed 13 Feb 2019.